Evidence map›Paper›PMID 33031446›Full record

ArticlePLoS pathogens2020

Poxvirus-encoded decapping enzymes promote selective translation of viral mRNAs.

Fernando Cantu, Shuai Cao, Candy Hernandez, Pragyesh Dhungel, Joshua Spradlin, Zhilong Yang

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Structural basis and dynamics of Chikungunya alphavirus RNA capping by nsP1 capping pores.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  10. Article
  11. Ribosomes in poxvirus infection.Current opinion in virology · 2022
    Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Eukaryotic mRNA Decapping Activation.Frontiers in genetics · 2022
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Fernando CantuDivision of Biology, Kansas State University, Manhattan, Kansas, United States of America.ORCID 0000-0002-2794-8761
Shuai CaoDivision of Biology, Kansas State University, Manhattan, Kansas, United States of America.ORCID 0000-0003-2361-1413
Candy HernandezDivision of Biology, Kansas State University, Manhattan, Kansas, United States of America.
Pragyesh DhungelDivision of Biology, Kansas State University, Manhattan, Kansas, United States of America.ORCID 0000-0002-7075-6415
Joshua SpradlinDivision of Biology, Kansas State University, Manhattan, Kansas, United States of America.ORCID 0000-0002-0092-9202
Zhilong YangDivision of Biology, Kansas State University, Manhattan, Kansas, United States of America.ORCID 0000-0001-8995-2654
Kansas State University · US

Funding

Mechanisms regulating poxvirus post-replicative protein synthesisR01AI143709 · NIAID · TEXAS A&M AGRILIFE RESEARCH · PI YANG, ZHILONG · 2019 to 2023
$1.9M
NIAID NIH HHS R01 AI143709
6 · The paper itself

Abstract

Cellular decapping enzymes negatively regulate gene expression by removing the methylguanosine cap at the 5' end of eukaryotic mRNA, rendering mRNA susceptible to degradation and repressing mRNA translation. Vaccinia virus (VACV), the prototype poxvirus, encodes two decapping enzymes, D9 and D10, that induce the degradation of both cellular and viral mRNAs. Using a genome-wide survey of translation efficiency, we analyzed vaccinia virus mRNAs in cells infected with wild type VACV and mutant VACVs with inactivated decapping enzymes. We found that VACV decapping enzymes are required for selective translation of viral post-replicative mRNAs (transcribed after viral DNA replication) independent of PKR- and RNase L-mediated translation repression. Further molecular characterization demonstrated that VACV decapping enzymes are necessary for efficient translation of mRNA with a 5'-poly(A) leader, which are present in all viral post-replicative mRNAs. Inactivation of D10 alone in VACV significantly impairs poly(A)-leader-mediated translation. Remarkably, D10 stimulates mRNA translation in the absence of VACV infection with a preference for RNA containing a 5'-poly(A) leader. We further revealed that VACV decapping enzymes are needed for 5'-poly(A) leader-mediated cap-independent translation enhancement during infection. Our findings identified a mechanism by which VACV mRNAs are selectively translated through subverting viral decapping enzymes to stimulate 5'-poly(A) leader-mediated translation.

Indexed as

Cell LineDNA ReplicationDNA, ViralHumansPoxviridaeRNA CapsRNA, ViralVaccinia virusViral ProteinsVirus ReplicationDNA, ViralRNA CapsRNA, ViralViral Proteins

Identifiers

PMID33031446
PMCPMC7575113
OpenAlexW3091779731

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.